Cover Image
市場調查報告書

左右醫療產業的未來技術

Technologies Impacting the Future of the Healthcare Sector

出版商 Technical Insights (Frost & Sullivan) 商品編碼 358083
出版日期 內容資訊 英文 127 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
左右醫療產業的未來技術 Technologies Impacting the Future of the Healthcare Sector
出版日期: 2016年05月12日 內容資訊: 英文 127 Pages
簡介

技術進步讓醫療產業開始與傳統完全不同的躍進。目前持續擴大中的動向是個別化醫療與精密醫療。另外還有活用微生物群的治療、光遺傳學、3D列印等明顯的技術進步。以及可戴式設備與行動醫療、遠距醫療等考慮病患面的技術活動。

本報告針對最新醫療技術、動向與商業模式進行徹底分析、提供商業與投資決定者策略計劃重要市場預測情報。

第1章 摘要整理

  • 調查範圍
  • 調查方法
  • 促進醫療產業變革的新商業模式
  • 讓商業模式被採用的主要成功因素
  • 醫療革新的新技術

第2章 業界概要

  • 市場概略
  • 醫療市場預測

第3章 技術動向與市場動向

  • 智慧手機與應用程式、可戴式設備擴大病患的範圍
  • 以個人化、價值為基準的醫療
  • 醫療應用動向

第4章 醫療最大的革新技術

第5章 微生物群技術

  • 消化道微生物群產生新治療法的可能性
  • 2015年不停止的專利活動
  • 找出微生物群的商業價值
  • 次世代微生物群技術
  • 微生物群的生物技術企業
  • 從個別化醫療到承受度更高的穀物

第6章 光遺傳學

  • 分析與修復大腦的技術
  • 盲目治療帶來有希望的結果讓提供資金急速增加
  • 創紀錄的神經科學研究工具
  • 創新擴大了適用的範圍
  • 世界的市場競爭狀況
  • 最佳實施商業模式

第7章 個人化基因

  • 大數據分析是實現個人化基因的條件
  • 創業投資矚目基因檢測的先端技術
  • 藥物基因是重要的適用分類
  • 個人化基因診斷具有豐富的革新
  • 癌症檢測是革新重要的重點領域
  • 直接販售給消費者的基因檢測受到注目

第8章 靶向給藥

  • 奈米技術的進步促進市場成長
  • 對精密醫療的需求促進資金投入與增加知慧財產權活動
  • 腫瘤是最有希望的研究領域
  • 新世代給藥技術發展
  • 由勝□傳達給特定細胞的技術尚在臨床階段
  • 初期商業模式與臨床階段受到藥廠與研究中心的注意

第9章 3D生物列印

  • 改變了再生醫療
  • Organovo與密蘇里大學是主要專利權者
  • 3D列印的組織與實際藥效尚在毒性測試階段
  • 化菻~測試用的皮膚目前開發中
  • 主要企業:從醫療移植到人工皮膚
  • 新商業模式: 環境劇變

第10章 床邊診斷設備

  • 不需診間可即時獲得高可信度的結果
  • 各種專利涵蓋技術領域
  • 活用動向: 一般醫藥品的測試組與處方籤測試組
  • 床邊診斷設備重要創新
  • 許多企業加入但尚未有領導企業
  • 今後持續的商業模式將重視擴大顧客範圍

第11章 行動醫療與遠距醫療

  • 行動醫療消費者的增加
  • 技術進步讓家居醫療增加
  • 行動醫療需要加深與病患的聯繫
  • 為了擴大醫療保險支付遠距醫療急速增加
  • 重要的市場動態
  • 價值基礎的商業模式重視滿足病患需求

第12章 可戴式設備

  • 因便利讓一般消費者與企業引進
  • 糖尿病是可戴式設備投入資金的重點項目
  • 重要的實施技術
  • 活用動向
  • 可戴式設備的創新重點之一是即時治療
  • 可實行技術的全球相關人士分類
  • 可戴式設備預計未來2年內將廣泛被引進

第13章 生物感應器

  • 與日常生活結合
  • 生物感應器與可戴式設備內結合的可能讓資金增加
  • 企業系統整合成為新用途
  • 更積極的醫療動向
  • 北美與歐洲為高度家庭用設備需求主要市場
  • 生物感應器適用機會與創新機會

第14章 醫療用雲端運算

  • 重要的調查結果
  • 加強雲端彈性與機動性
  • 服務與引進方式的彈性
  • 醫療雲端運算: 概要
  • 世界各國政府轉向雲端
  • 使用付費形態的商業模式降低成本提高引進率
  • 具有效率的健康訊息接受度高
  • 系統平台降低整體價值鏈成本
  • 強化客製化與主動技術
  • 雲端運算平台由北美領導

第15章 醫療大數據分析

  • 大數據:改善診斷、研究與病患治療成果
  • 更有效率的活用醫療資源
  • Internet of Me (IoM) 的活動
  • 市場動向優點
  • 大數據實現後可以進化為個人化醫療
  • 美國國立衛生研究所促進大數據研究者間的資料交換提供資金援助
  • 主要創新重視應用範圍
  • 創新加速產品開發與精密醫療
  • 風險分析與預防分析讓資金投入與智慧產權行動擴大
  • 新的價值促進適用領域
  • 北美在大數據競爭中領先
  • DNA網路是今後的先驅

第16章 技術藍圖

  • 技術、應用、顧客與商業模式藍圖 - 2016年到2020年世界市場

第17章 分析師考察

  • 醫療產業價值鏈的變革動向
  • 革新商業模式
  • 個人化醫療與精密醫療的商業模式
  • 免責條款

第18章 關於Frost & Sullivan

目錄
Product Code: D6F9-01-00-00-00

Evaluating the Role of Disruptive Technologies in Transforming the Delivery of Healthcare

Technological advancements are disrupting the healthcare industry. There is an increasing trend toward personalized and precise medical treatments, such as personalized genomics, which provide outputs at a much lower cost and at a faster speed than has ever been possible. Precision medicine has also driven the development of targeted drug delivery, which improves the efficacy of drugs, while reducing side effects. The increasing occurrence of auto-immune disorders has spurred research interest in microbiome therapies, which focus on using the body's own microbiota as a defense against pathogens. Another hot technology area revolutionizing neuroscience is optogenetics, which attempts to rewire the brain through the use of optics and genetics. The success of optogenetics in vision recovery has provided an impetus for funding in this space. The rising incidence of chronic and lifestyle disorders, along with the difficulty of finding donors, has led to research in printing live tissue, currently used in pharma for toxicology testing. Long-term R&D in this space is geared toward the development of 3D printed organs, which truly represent the next frontier in healthcare advancement.

However, just as technologies are disrupting healthcare, the reverse can be said to hold true. Healthcare is moving toward increased patient empowerment, leading to the development of wearables, mHealth and telemedicine. Advances in Big Data and Cloud Computing have enabled more real-time healthcare solutions such as biosensors, leading to greater patient engagement. Digital transformation has also been key to enabling path-breaking development in genomics platforms, such as rapid genome sequencing. Organizations are moving toward new care delivery models that increasingly focus on delivering patient value, leading to redefined revenue pathways. This research service provides a deep-dive analysis into some of the most disruptive technologies, trends and business models impacting healthcare today, providing decision-makers with key insights for strategic planning.

Table of Contents

1. EXECUTIVE SUMMARY

  • Scope of Research
  • Research Methodology
  • Emerging Business Models Transforming the Healthcare Industry
  • Key Success Factors for Adoption of a Business Model
  • Emerging Technologies Transforming Healthcare

2. INDUSTRY OVERVIEW

  • Market Snapshot
  • Healthcare Market Predictions

3. TECHNOLOGY AND MARKET TRENDS

  • Smartphones, Apps and Wearables Increase Patient Empowerment
  • A Move Toward Personalized, Value-based Medicine
  • Trending Healthcare Applications

4. THE BIGGEST GAME CHANGERS IN HEALTHCARE

5. MICROBIOME TECHNOLOGIES

  • The Gut microbiome Could Lead to New Therapies
  • Continuous Patenting Activity in 2015
  • Harnessing Commercial Value from Microbiomes
  • Next-gen Microbiome Technologies
  • Biotech Companies in the Microbiome Space
  • From Personalized Medicine to More Resistant Crops

6. OPTOGENETICS

  • Technology for Mapping and Repairing the Brain
  • Promising Results in Treating Blindness spur Funding
  • A Revolutionary Neuroscience Research Tool
  • Innovations Span Diverse Application Areas
  • Global Competitive Landscape
  • Best Practices Business Models

7. PERSONALIZED GENOMICS

  • Big Data Analytics is Key to Enabling Personalized Genomics
  • VCs on the Lookout for Cutting-edge Technologies in Genetic Testing
  • Pharmacogenomics is a Key Application Area
  • Innovations in Personalized Genome Diagnostics Abound
  • Cancer Testing is an Important Focus Area for Innovators
  • Direct-to-Consumer Genome Tests Gaining Traction

8. TARGETED DRUG DELIVERY

  • Advances in Nanotechnology Drive the Market
  • The Demand for Precision Medicine Drives Funding and IP
  • Oncology is the Most Promising Research Area
  • New-Age Drug Delivery Technologies Thrive
  • Several Peptides in Clinical Trials for Cell-Specific Delivery
  • Business Models Target Early and Clinical-stage Pharma, Research Centers

9. 3D BIOPRINTING

  • Changing the Face of Regenerative Medicine
  • Organovo and University of Missouri are Key Patent Holders
  • 3D Printed Tissue Effective for Drug and Toxicity Testing
  • Skin Models Are Being Developed for Cosmetic Testing
  • Key Market Players : From Medical Implants to Artificial Skin
  • Emerging Business Models: A Paradigm Shift

10. POINT-OF-CARE DIAGNOSTIC DEVICES

  • Instant and Reliable Results Without Requiring a Lab
  • Patent Trends Cover Diverse Technology Areas
  • Trending Applications: Over-the-Counter (OTC) Test Kits and Prescription-based Kits
  • Key Innovations in Point-of-Care Diagnostic Devices
  • Many Market Players in the PoC Space With no Clear Leader
  • Business Models Will Continue to Focus on Customer Empowerment

11. MHEALTH AND TELEMEDICINE

  • The Rise of the Mobile Health Consumer
  • Technological Advances Will Enable More At-home Care
  • mHealth is Necessary for Increased Patient Engagement
  • Expanding Reimbursement Options Boost Telemedicine
  • Market Dynamics across Key Sectors
  • Value-based Business Models Focus on Patient Satisfaction

12. WEARABLES

  • Convenience Drives Adoption for Consumers and Businesses
  • Diabetes is an Important Wearables Funding Focus
  • Key Enabling Technologies
  • Key Enabling Technologies (continued)
  • Trending Applications
  • Innovations in Wearables Focus on on Real-time Intervention
  • Global Stakeholders by Enabling Technologies
  • Wearables Will be Widely Adopted Within the Next Two Years

13. BIOSENSORS

  • Seamless Integration into Everyday Living
  • Potential of Integrating Biosensors Into Wearables Spurs Funding
  • New Applications Will Emerge With Increased Integration Into Enterprise Systems
  • A Move Toward More Actionable Healthcare
  • NA and EU are Key Markets with a High Demand for Home-based Devices
  • Application & Innovation Opportunities in Biosensors

14. CLOUD COMPUTING FOR HEALTHCARE

  • Key Findings
  • Increased Flexibility and Agility With the Cloud
  • Versatility in Service and Delivery Options
  • Cloud Computing in Healthcare: An Overview
  • Governments Worldwide are Promoting the Shift to the Cloud
  • Pay-per-use Business Models Help Lower Cost and Increase Adoption
  • Efficient Health Information Exchange Encourages Adoption
  • Platforms Aim at Reducing Costs Across the Value Chain
  • Enhancing Customized and Proactive Solutions
  • North America is the Leader in Cloud Computing Platforms

15. BIG DATA ANALYTICS FOR HEALTHCARE

  • Big Data: Improving Diagnostics, Research and Patient Outcomes
  • Enabling a more Efficient Use of Healthcare Resources
  • A Move Toward the Internet of Me
  • Trending Benefits
  • More Personalized Medical Care Enabled by Big Data
  • The NIH is Funding Big Data to Facilitate Data Exchange Among Researchers
  • Key Innovators Focus on a Diverse Range of Applications
  • Product Development, Precision Medicine Drive Innovation
  • Increased Funding and IP toward Risk and Preventive Analytics
  • Applications Areas Driven by New Value Pathways
  • North America Leads the Big Data Race
  • The Internet of DNA is the next Frontier

16. TECHNOLOGY ROADMAPPING

  • Roadmap of Technologies, Applications, Customers, and Business Models-Global, 2016-2020

17. ANALYST INSIGHTS

  • Trends Transforming the Healthcare Value Chain
  • Transformative Business Models
  • Business Models Shaping Personalized and Precision Medicine
  • Legal Disclaimer

18. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top